Assessment of urinary neutrophil gelatinase-associated lipocalin for the early detection of renal dysfunction among children with beta thalassemia major

Read full text Summarise with VIRAT
Authors: Asmaa A. Hewila, Rasha Emad Badr, Mona I. Salma, Nesrin Mosad Handoka, Mona M. Ismail
Cited by: 0
References: 14

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background Thalassemia results in ineffective erythropoiesis, chronic anemia, and hemolysis, often requiring transfusions that lead to secondary iron overload. the renal damage is a common complication in beta thalassemia due to Tubular dysfunction. Conventional renal markers such as serum creatinine (SCr) and proteinuria lack sensitivity for early detection of kidney injury. Novel noninvasive biomarkers, particularly neutrophil gelatinase-associated lipocalin (NGAL), show promise for the timely identification of renal dysfunction in this population. Aim To detect the early renal impairment in children with beta thalassemia major (β-TM). Patients and methods The current case-control study was performed in Port Said hospitals, included 56 patients, 36 β-thalassemia children, 20 age- and sex-matched healthy controls. Key history and physical examination were done on both groups. Laboratory data include complete blood counts, serum biochemical analyses including serum urea (s. urea) SCr, serum potassium, serum ferritin, also urine samples were collected and analyzed to measure the level of NGAL in all groups. Results The results showed a statistically significant increase in urinary NGAL in the β-TM patients group compared with the control group ( P

Fields of Study & Subjects

Hemoglobinopathies and Related Disorders Acute Kidney Injury Research Chronic Kidney Disease and Diabetes

Publication details

Journal / source
The Egyptian Journal of Haematology
Volume
51
Issue
1
Pages
180–185
Publication date
1 January 2026
Language
EN